The CEO of Sigrid Therapeutics, Sana Alajmovic, has both been named one of the Female Leaders of the Future and won the Life Science category of the Nova 111 list.
The aim with the list is to find the most talented professionals younger than 36 years of age by ability and potential, regardless of gender and background. The list of talents is evidence-based and meritocratic, as each person is tested and assessed through tried and tested selection methodologies.
Having the guts to challenge existing structures
Sana Alajmovic was recently also named, for the second consecutive year, as one of the Female Leaders of the Future by the Swedish managers’ organisation Ledarna. The award is given to female leaders that are making a difference and highlights the value of good leadership.
“To me leadership is about having the guts to challenge existing structures. I am frustrated to live in a society where we focus more on managing disease than preventing it. With Sigrid I want to build a company and drive a societal change towards preventive health,” says Sana Alajmovic.